Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.
Authors: Wu YS; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway. yansiw@medisin.uio.no., Burger EA; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Holmboe F; AbbVie, Oslo, Norway., Bangum M; AbbVie, Oslo, Norway., Oteiza F; Oslo Economics, Oslo, Norway., Bugge C; Oslo Economics, Oslo, Norway., Sæther EM; Oslo Economics, Oslo, Norway., Aas E; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.; Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway.
Source: PharmacoEconomics - open [Pharmacoecon Open] 2026 Jul; Vol. 10 (4), pp. 679-694. Date of Electronic Publication: 2026 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing AG Country of Publication: Switzerland NLM ID: 101700780 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-4254 (Electronic) Linking ISSN: 25094262 NLM ISO Abbreviation: Pharmacoecon Open Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42315785
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wu+YS%22">Wu YS</searchLink>; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway. yansiw@medisin.uio.no.<br /><searchLink fieldCode="AU" term="%22Burger+EA%22">Burger EA</searchLink>; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Holmboe+F%22">Holmboe F</searchLink>; AbbVie, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Bangum+M%22">Bangum M</searchLink>; AbbVie, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Oteiza+F%22">Oteiza F</searchLink>; Oslo Economics, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Bugge+C%22">Bugge C</searchLink>; Oslo Economics, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Sæther+EM%22">Sæther EM</searchLink>; Oslo Economics, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Aas+E%22">Aas E</searchLink>; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.; Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101700780%22">PharmacoEconomics - open</searchLink> [Pharmacoecon Open] 2026 Jul; Vol. 10 (4), pp. 679-694. <i>Date of Electronic Publication: </i>2026 Jun 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing+AG%22">Springer International Publishing AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101700780 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2509-4254 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225094262%22">25094262 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoecon Open <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42315785
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s41669-026-00656-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 679
    Titles:
      – TitleFull: Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wu YS
      – PersonEntity:
          Name:
            NameFull: Burger EA
      – PersonEntity:
          Name:
            NameFull: Holmboe F
      – PersonEntity:
          Name:
            NameFull: Bangum M
      – PersonEntity:
          Name:
            NameFull: Oteiza F
      – PersonEntity:
          Name:
            NameFull: Bugge C
      – PersonEntity:
          Name:
            NameFull: Sæther EM
      – PersonEntity:
          Name:
            NameFull: Aas E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2509-4254
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: PharmacoEconomics - open
              Type: main
ResultId 1